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a b s t r a c t
The safety, including the endocrine disruptive capability, of glyphosate-based herbicides (GBHs) is a
matter of intense debate. We evaluated the estrogenic potential of glyphosate, commercial GBHs and
polyethoxylated tallowamine adjuvants present as co-formulants in GBHs. Glyphosate (10,000 mg/L or
59 mM) promoted proliferation of estrogen-dependent MCF-7 human breast cancer cells. Glyphosate also
increased the expression of an estrogen response element-luciferase reporter gene (ERE-luc) in T47D-
KBluc cells, which was blocked by the estrogen antagonist ICI 182,780. Commercial GBH formulations
or their adjuvants alone did not exhibit estrogenic effects in either assay. Transcriptomics analysis of
MCF-7 cells treated with glyphosate revealed changes in gene expression reﬂective of hormone-induced
cell proliferation but did not overlap with an ERa gene expression biomarker. Calculation of glyphosate
binding energy to ERa predicts a weak and unstable interaction (4.10 kcal mol1) compared to estradiol
(25.79 kcal mol1), which suggests that activation of this receptor by glyphosate is via a ligand-
independent mechanism. Induction of ERE-luc expression by the PKA signalling activator IBMX shows
that ERE-luc is responsive to ligand-independent activation, suggesting a possible mechanism of
glyphosate-mediated activation. Our study reveals that glyphosate, but not other components present in
GBHs, can activate ERa in vitro, albeit at relatively high concentrations.
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Glyphosate-based herbicides (GBHs) are the most widely used
pesticides worldwide. Glyphosate acts as a herbicide by inhibiting
the enzyme 5-enolpyruvylshikimate 3-phosphate synthase
(EPSPS), causing a shortage of aromatic amino acids (Boocock and
Coggins, 1983). Glyphosate occupies the binding site of the sec-
ond substrate of EPSPS (phosphoenol pyruvate), mimicking an in-
termediate state of the ternary enzyme substrate complex
(Schonbrunn et al., 2001). GBH are commercialized in the form of
mixtures consisting of glyphosate and various co-formulants,
which are required to stabilise and allow penetration of glypho-
sate into plants. The major class of co-formulants is represented by
surfactants. They are generally included in commercial GBH for-
mulations, but are also sold and used separately as adjuvants and
added during the preparation of the agriculturally applied pesticide
mixture. In 2014, the amount of GBH sprayed by farmers was
equivalent to glyphosate being applied at 0.53 kg/hectare on all
cropland worldwide (Benbrook, 2016). Glyphosate is routinely
detected in foodstuffs (EFSA, 2014), air and rain (Majewski et al.,
2014). The half-life of glyphosate is variable depending on envi-
ronmental conditions. For example, it ranged from 47 to 315 days
depending on light and temperature in a study using coastal
seawater from the Great Barrier Reef (Mercurio et al., 2014).
Epidemiological data on the human body burden of GBH residues is
very limited but evidence suggests that glyphosate and its metab-
olites are wide-spread (Niemann et al., 2015). Although the
contamination of human biological ﬂuids by compounds used as
co-formulants in commercial pesticides is poorly investigated, their* Corresponding author.
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presence in food (Ferrer et al., 2011) and in the environment (Berge
et al., 2012; Tush and Meyer, 2016) is well documented.
A number of in vivo toxicity studies have suggested effects of
glyphosate and its commercial formulations on reproductive or-
gans (Mesnage et al., 2015a). This includes studies on the uterus
(Guerrero Schimpf et al., 2017), the hypothalamice
pituitaryegonadal axis (Romano et al., 2012), testis (Cassault-
Meyer et al., 2014) and ovaries (Armiliato et al., 2014). However,
it is not clear whether toxic effects observed in these studies are
due to endocrine disrupting mechanisms or result from a more
general cytotoxicity mechanism. Glyphosate was suggested to have
endocrine interference properties by inhibiting aromatase enzyme
activity (Richard et al., 2005) and activating estrogen receptors (ER)
(Thongprakaisang et al., 2013). In contrast, no evidence of potential
interaction of glyphosate with the estrogen pathway has been
detected in the Endocrine Disruptor Screening Program (EDSP)
conducted by the US Environmental Protection Agency (EPA) (US
EPA, 2015). Thus the endocrine disruptive capability of glyphosate
remains uncertain.
Other modes of action can also be postulated for glyphosate-
induced toxicity in a number of diverse species. Glyphosate inhi-
bition of EPSPS in plants is by competitive inhibition of its substrate
phosphoenolpyruvate (PEP) binding at the enzyme active site
(Schonbrunn et al., 2001). Enzymes binding PEP are regulators of
energymetabolism, in particular through the TCA cycle. Glyphosate
off-target effects may include the disruption of these enzymes.
Glyphosate can also interact at the substrate binding site and
potentially inhibit mitochondrial succinate dehydrogenase (Ugarte,
2014). Overall, glyphosate has multiple non-speciﬁc biological ac-
tivities and has been patented for a number of purposes, including
use as aweedkiller (U.S. Patent No 3,799,758), a metal chelator (U.S.
Patent No. 3,160,632), an anti-cancer and anti-viral compound (U.S.
Patent No 5665713 A), and an anti-parasitic agent (U.S. Patent No
7771736 B2).
Surfactants contained in GBH can also be a source of toxicity
(Mesnage et al., 2013). Populations of farmers exposed to adjuvants
such as solvents or petroleum distillates presented a higher risk of
developing hypospadias (Carmichael et al., 2013) and more allergic
and non-allergic wheeze (Hoppin et al., 2017). However, the spe-
ciﬁc role of the pesticide-derived surfactants versus other sources
of similar compounds found on farms is currently unknown. Since
previous toxicity studies have revealed that the polyethoxylated
tallowamine (POEA) class of adjuvants are potent toxicants in vitro
(Mesnage et al., 2013), the investigation of the toxicological proﬁle
of POEA has been deﬁned as a priority by the European Food Safety
Authority (EFSA) (EFSA, 2015).
In order to address some of the gaps in the evidence pertaining
to the endocrine disrupting capability of glyphosate and GBHs in
general, we examined the estrogenic potential of these compounds
in three human breast cancer cell lines. The effects of glyphosate,
two forms of POEA co-formulant (technical grade and agricultural
spray adjuvant) and 4 commercial GBH formulations containing
different ratios of co-formulants were compared to estradiol and
the known estrogen mimic bisphenol A (BPA). The E-screen assay
employing cell proliferation of MCF-7 estrogen-dependent cells
and an estrogen responsive element (ERE)-luciferase reporter gene
assay in T47D-KBluc cells were used. In addition, effects on the
transcriptome in hormone dependent MCF-7 cells using a micro-
array platform and by RNA-seq were also determined to ascertain if
alterations in the gene expression proﬁles correlate with an
established gene expression proﬁle signature used to accurately
predict estrogen receptor a (ERa) modulation (Ryan et al., 2016).
Moreover, it is known that the activation of ER can be caused by the
modulation of the phosphorylation of certain protein kinases due to
the interplay between cellular signalling pathways (Driggers and
Segars, 2002). These different modes of action can be revealed by
transcriptomics analysis as they have distinct gene expression
signatures (Dudek and Picard, 2008). The quantum mechanical
behaviour of glyphosate ions within the ligand binding domain
(LBD) of ERa was assessed using molecular dynamic simulation.
Own N-layered Integrated Molecular Orbital and Molecular me-
chanics (ONIOM) calculations were undertaken from the lowest
energy structures of molecular dynamic simulations in order to
evaluate the binding energy of complexes.
Our results reveal that glyphosate (>10,000 mg/L) but none of
the other compounds tested activate ERa. The predicted weak
interaction between ERa and glyphosate, suggests that gene acti-
vation by this compound is through other mechanisms (for
example, a non-ligand binding mechanism) than direct binding to
the receptor.
2. Material and methods
2.1. Reagents
All reagents and chemicals, unless otherwise speciﬁed, were of
analytical grade and were purchased from Sigma-Aldrich (Gilling-
ham, Dorset, UK). Glyphosate (CAS Number: 1071-83-6) used was
the PESTANAL® analytical standard (98.0%) obtained from Sigma-
Aldrich (UK). The batch of glyphosate (98.0%) purchased from
AccuStandard (New Haven, CT, USA) was tested exclusively in the
ERE transcription luciferase reporter gene assay in an attempt to
replicate previously published conditions and results suggesting
estrogenic effects (Thongprakaisang et al., 2013). GBH formulations
available on the market were Glyphogan (France, 39e43% iso-
propylamine salt of glyphosate, 13e18% of POEA (CAS 61791-26-2),
homologation 9100537), Roundup Grand Travaux Plus (France,
450 g/L of glyphosate, 90 g/L of ethoxylated etheralkylamine, ho-
mologation 2020448), Roundup Original DI (Brazil, 445 g/L of
glyphosate diammonium salt, 751 g/L of other ingredients, ho-
mologation no 00513) and Roundup Probio (UK, 441 g/L of the
potassium salt of glyphosate, other ingredients, Registration
Number 15539). These formulations were selected as they contain
different types of surfactants (Mesnage et al., 2013), which could
have different toxic effects. POEAwas purchased from ChemService
(West Chester, PA, USA). The agricultural spray adjuvant was Gen-
amin T200 (France, 60e80% of POE-15, homologation 8500170).
2.2. Cell culture
The MCF-7, MDA-MB-231 and T47D cell lines were a kind gift
from Prof Joy Burchell (Research Oncology Department, King's
College London). T47D-KBluc cells were purchased from the
American Type Culture Collection (ATCC, Teddington, UK) and
harbour a stably integrated copy of a luciferase reporter gene under
control of a promoter containing ERE (Wilson et al., 2004).
All cells were grown at 37 C (5% CO2) in 75 cm2 ﬂasks (Corning,
Tewksbury, USA) in a maintenance medium composed of phenol
red free DMEM (Life Technologies, Warrington, UK), 10% fetal
bovine serum (FBS; GE Healthcare Life Sciences, Buckinghamshire,
UK), 2 mM glutamine (GE Healthcare Life Sciences) and 10 mg/ml
penicillin/streptomycin (Life Technologies). Stock solutions of
glyphosate, glyphosate-based herbicides, POEA and Genamin T200
surfactant formulation were prepared in serum-free medium and
adjusted to pH 7.2. All assays described below have been performed
at this pH. Estradiol, 3-isobutyl-1-methylxanthine (IBMX), and BPA
were diluted in 100% ethanol to prepare stock solutions. Solvent
concentrations for these two compounds were always below 0.5%
(cell assays) and 0.0005% (transcriptome proﬁling). All treatments
were diluted in a test medium containing phenol red free DMEM,
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5% charcoal stripped FBS (Life Technologies, UK), 2 mM glutamine
(GE Healthcare Life Sciences) and 10 mg/ml penicillin/streptomycin
(Life Technologies, UK). Cells were released from the ﬂask substrate
using 0.05% trypsin EDTA (Life Technologies, UK) and counted using
a haemocytometer prior to seeding. A 24 h recovery period was
allowed for cell adherence in DMEM maintenance medium before
cultures were subjected to the desired treatments.
2.3. E-screen assay
The E-screen allows the determination of estrogenic effects by
determining ER-mediated cell proliferation in hormone responsive
cells. This assay was performed as originally described (Soto et al.,
1995) except that it was terminated using a MTT assay (Mosmann,
1983). Additionally, this test allows the measurement of cytotoxic
effects since activity of mitochondrial dehydrogenase enzymes
indirectly reﬂects cellular mitochondrial respiration (Mosmann,
1983). Brieﬂy, cells were seeded into 48 well plates (Dutscher Sci-
entiﬁc, Brentwood, Essex, UK) at a density of 20,000 cells per well
in 250 ml maintenance medium. Following a 24 h incubation to
allow cell attachment, the medium was changed to the medium
containing the compounds. The test medium was refreshed after 3
days. Following another 3-day period of incubation, an MTT assay
was performed as follows. Cells were incubated with 250 ml of MTT
solution (1 mg/ml) for 2 h. The test was terminated by lysing the
cells with dimethyl sulfoxide (DMSO) and optical density measured
at 570 nm using the SPECTROstar Nano plate reader (BMG Labtech,
Aylesbury, Bucks, UK). The proliferative effect was expressed as a
percentage of the control cell culture receiving no treatment.
2.4. ERE-luciferase reporter gene assay
The ERE-mediated transcription of a luciferase reporter gene
was determined in the T47D-KBluc cells using the Steady-Glo®
luciferase assay system following the manufacturer's instructions
(Promega, Southampton, UK). T47D-KBluc cells were seeded in
white 96 well plates (Greiner Bio-One, Germany) at a density of
20,000 cells per well in 50 ml of maintenance medium and allowed
to attach overnight. An initial 24 h incubationwas performed in the
absence of test substances in order to improve residual estrogen
clearance and thus assay sensitivity. Test substances were added
and plates were incubated for another 24 h before the addition of
50 ml Steady-Glo® luciferase reagent. The plates were left to stand
for 10 min in the dark at room temperature to allow cell lysis.
Bioluminescence was measured using the Orion II microplate
luminometer (Berthold Detection Systems, Bad Wildbad, Ger-
many). ER-mediated gene activation by test substances was
conﬁrmed by ascertaining if observed effects were subject to in-
hibition by the addition of 100 nM of the estrogen antagonist ICI
182,780 (CAS 129453-61-8) on induced luciferase activity.
2.5. Microarray gene expression proﬁling
MCF-7 cells were seeded into 96-well plates with maintenance
medium at a density of 20,000 cells per well. After 24 h of steroid
deprivation in hormone free medium, the cells were stimulated
with test substances for 48 h in triplicate in three independent
experiments. RNA extraction was performed using the Agencourt
RNAdvance Cell V2 kit according to the manufacturer's instructions
(Beckman Coulter Ltd, High Wycombe, UK). The samples were
checked for RNA quality using the Agilent 2100 Bioanalyzer and
quantiﬁed using a Nanodrop instrument (ND-1000 Spectropho-
tometer; Thermo Fisher Scientiﬁc, Wilmington, DE, USA). The RNA
integrity number (RIN) was 9.7 ± 0.3. Subsequently, technical
replicates of samples, which passed quality control (QC), were
pooled appropriately such that the ﬁnal input amount of each
biological replicate was 3 ng. Transcriptome gene expression pro-
ﬁles were determined using the Affymetrix Human Transcriptome
2.0 Array (Affymetrix, HighWycombe, UK) as follows. Single Primer
Isothermal Ampliﬁed (SPIA) cDNAwas generated using the Ovation
Pico WTA System V2 kit (Nugen, AC Leek, The Netherlands),
following the manufacturer's instructions. Furthermore, the SPIA
cDNA was subjected to a QC check to assess quality (Agilent 2100
Bioanalyzer) and quantity (Nanodrop ND-1000) for the next stage.
The SPIA cDNA was fragmented and Biotin-labelled using the
Encore Biotin Module (Nugen) according to the manufacturer's
instructions. The fragmented and Biotin-labelled cDNA was sub-
jected to a further round of QC checks to assess fragmentation size
(Agilent 2100 Bioanalyzer). Hybridisation cocktails of the frag-
mented labelled-cDNAwere then prepared (Nugen) and hybridised
at 45 C overnight. The arrays were washed and stained using wash
protocol FS450_0001 as recommended for Affymetrix Human
Transcriptome 2.0 Arrays on the GeneChip Fluidics 450 station.
Ultimately, the arrays were scanned using the Affymetrix GeneChip
Scanner. CEL ﬁles were quality control assessed in the Expression
Console software package (Affymetrix) by using standard metrics
and guidelines for the Affymetrix microarray system. Data were
imported and normalised together in Omics Explorer 3.0 (Qlucore,
New York, NY, USA), using the Robust Multi-array Average (RMA)
sketch algorithm. These microarray data have been submitted to
Gene Expression Omnibus (NCBI) and are accessible through
accession number GSE86472.
2.6. RNA-sequencing gene expression proﬁling
RNA sequencing was performed by applying Illumina
sequencing by synthesis technology as follows. Amount of RNAs for
each library (100 ng) was a pool made up of 33 ng of RNA from each
of the replicate wells for each sample. The preparation of the library
was conducted by NEBNext Ultra Directional RNA (New England
Biolabs, Hitchin, UK) following manufacturer's protocol. The
ampliﬁed library was assessed using the Agilent 2100 Bioanalyzer
for size and presence of adapter/primers/dimers, sized at ~400bp
(including ~130bp adapter). The rRNA component was removed
using the rRNA depletion module (New England Biolabs) following
manufacturer's protocol. Libraries were pooled and sequenced on
the Illumina HiSeq2500 platform (Illumina UK Chesterford, Essex,
UK) using a Rapid Run v2 ﬂowcell with on-board clustering in a
2 100 paired-end (PE) conﬁguration. BCL ﬁles were processed and
deconvoluted using standard techniques. The sequencing output
FASTQ ﬁles contain the sequences for each read and also a quality
score. We analyzed the quality scores and other metrics
using FASTQC (http://www.bioinformatics.babraham.ac.uk/
projects/fastqc/). Contamination from rRNA was measured using
an alignment script (http://genomespot.blogspot.co.uk/2015/08/
screen-for-rrna-contamination-in-rna.html). Adapter sequences
(standard TruSeq LT adapter seq) were removed/trimmed using
cutadapt (Martin, 2011). Sequences were then aligned to the hu-
man genome (hg38 database) using the hierarchical indexing for
spliced alignment of transcripts program HISAT2 (Kim et al., 2015).
BAM ﬁles were imported into the Qlucore omics explorer, along
with the GTF ﬁle for known genes in hg38 (downloaded from the
UCSC Genome Database). Qlucore normalises data using a method
similar to the trimmed mean of M-values normalization method
(TMM), which corrects for transcript length and applies a log
transformation (Robinson and Oshlack, 2010). This approach gives
values similar to the quantiﬁcation of transcript levels in reads per
kilobase of exon model per million mapped reads (RPKM)
(Robinson and Oshlack, 2010), and in addition, also incorporates
the TMM normalization factor for an improved between-sample
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normalization.
A total of 376.6 million raw reads were obtained (25.1 ± 5.4
million reads per sample). The average value of Q30, representing
the probability of an incorrect base call 1 in 1000 times, was above
96%. The GC content (%GC) of the reads was on average 49%. A total
of 90.92 ± 6.54% of the clean reads were mapped onto the human
reference genome hg38. Among them, an average of 71.01 ± 5.82%
and 18.25 ± 3.79% reads align concordantly exactly one time and
more than one time, respectively. These RNA-seq data have been
submitted to Gene Expression Omnibus (NCBI) and are accessible
through accession number GSE87701.
2.7. Statistical analysis
The ERE transcription luciferase reporter gene assay (n ¼ 4) and
the E-Screen assay (n ¼ 6) were performed 4 and 6 times in trip-
licate, respectively. Concentrations required to elicit a 50% response
(AC50) were determined using a nonlinear regression ﬁt using a
sigmoid (5-parameters) equation calculated with GraphPad soft-
ware (GraphPad Software, Inc., La Jolla, CA, USA). For the tran-
scriptome analysis, pair-wise comparisons of each tested substance
to the negative control were performed using a t-test controlling for
batch effects in Omics Explorer 3.0 (Qlucore, New York, NY, USA).
Affymetrix microarray and RNA-seq gene expression proﬁling were
performed 3 times in triplicate.
Data used for the functional analysis were selected at cut off p-
values of <0.05 with fold change >1.2 to evaluate the ER activation
signature as previously described (Ryan et al., 2016). Gene and
disease ontology were analyzed using the Thomson Reuters Met-
aCore Analytical Suite recognizing network objects (proteins, pro-
tein complexes or groups, peptides, RNA species, compounds
among others). The p-values are determined by hypergeometric
calculation and adjusted using the method of Benjamini &
Hochberg.
2.8. Molecular dynamic simulations and ONIOM calculations
The atomic coordinates of the complex formed by estradiol (ES)
and the human ERa ligand binding domain were taken from the
Protein Data Bank (entry code 1A52). For the construction of the
model, only chain A of the homodimer was included, and the sec-
ond set of duplicate coordinates was deleted. The protein contains
239 amino acids in the modelled monomer, starting from Leu 306
and ending with Leu 544. Coordinates for missing amino acid res-
idues (297e305, 545e554), missing heavy atoms and hydrogen
atoms, were reconstructed with the LEaP module of AmberTools 15
package (Case et al., 2015) and by using the AMBER FF14SB force
ﬁeld. The ﬁnal ER contained 258 amino acid residues. All Arg, Lys,
Asp, and Glu residues were modelled as charged, all tyrosines as
neutral, and histidine residues were modelled according to pub-
lished models (Celik et al., 2007). Of the 13 residues of histidine,
three residues were protonated (ion imidazolium) in order to
preserve the electroneutrality of the system (Table 1). Histidine 524
was chosen because it serves as a communication point between
the ligand and the receptor by establishing a hydrogen bond
network necessary to activate the ER (Celik et al., 2007). The
termini were modelled as charged. Glyphosate was docked into the
ER by using the ArgusLab software (M. A. Thompson, 2004). Since
the charge of glyphosate (G) is 2, the ligand-receptor system was
kept neutral by changing the charge of histidine residues of the
environment (medium that surrounds the active site; that is, the
remaining protein plus water) or of the active site itself (Table 1).
The amino acid residues that form the active site are: LEU 346, LEU
349, ALA 350, GLU 353, LEU 384, LEU 387, MET 388, LEU 391, ARG
394, PHE 404, MET 421, ILE 424, LEU 428, GLY 521, Histidine 524,
LEU 525, MET 528. The Estradiol-Estrogen Receptor (ES-ER),
Glyphosate-Estrogen Receptor (G-ER), and ER systems were sol-
vated in a pre-equilibratedwater box using the TIP3P solventmodel
and extending 10 Å beyond the protein. Electrostatic potentials of
estradiol (C18H24O2) and glyphosate (C3H6NO5P2) were calculated
with the Gaussian 09 program using the HF/6-31G(d) level of
theory (Frisch et al., 2009). Partial charges were ﬁtted with the
Restrained Electrostatic Potential (RESP) method (Bayly et al., 1993)
using the Antechamber module of AmberTools 15. General AMBER
force ﬁeld (GAFF) parameters for glyphosate were assigned by LeaP
(Wang et al., 2004).
2.8.1. Molecular dynamics simulations
All simulations were carried out with the SANDER module of
AmberTools 15 in periodic boundary conditions. All bonds
involving hydrogen atoms were constrained by using the SHAKE
algorithm (Ryckaert et al., 1977). The particle mesh Ewald (PME)
method was used to treat long-range electrostatic interactions
(Petersen, 1995). Temperature regulation was done using a Lange-
vin thermostat with collision frequency of 2 ps1. Prior to the
molecular dynamic simulations we performed an energy minimi-
zation in order to remove the largest strains in the systems, then
each systemwas gradually heated in the NVT ensemble from 0 K to
310 K over a period of 70 ps. The production runs of 5 ns were
performed in an NPT ensemble at 310 K and a pressure of 1 atm
employing a Berendsen barostat; the time step of the simulations
was 2 fs with a non-bonded cut-off of 10 Å. Snapshots were
extracted every 0.5 ps. The potential energy was automatically
analyzed for each of the 10000 snapshots from each model. The
result obtained from this analysis allows ﬁnding the structure or
conformation of lowest energy. Visualizations of glyphosate and
estradiol interactions with ER were produced using the Chimera
visualization system (Pettersen et al., 2004).
2.8.2. QM/MM (quantum mechanics/molecular mechanics)
calculations
The conformations of lowest energy corresponding to each
model are submitted to geometry optimization. The AMBER opti-
mized structures were used as a starting point for the QM/MM
calculations, except the different ER versions, which are derived
from its respective complexes by elimination of the ligand. These
structures obey the conformational selection hypothesis
(McGowan Lauren and Hamelberg, 2013). Water molecules that
were within ~10 Å of the protein surface were kept for the QM/MM
calculations. All other water molecules were deleted to facilitate
the computation (Humphrey et al., 1996). Moreover, in the QM/MM
calculations, all residues within 7 Å of the core active site residues
were allowed to move without any constraints, while all other
residues were frozen (Tao et al., 2009; Tao and Schlegel, 2010).
In QM/MM hybrid methods, part of the system that includes the
chemically relevant region is treated quantum mechanically (QM)
while the remainder, often referred to as the environment, is
treated at the classical level using molecular mechanics (MM) force
ﬁelds. This multiscale approach reduces the computational cost
signiﬁcantly as compared to a QM treatment of the entire system
and makes simulations possible that otherwise would not be
feasible (Gotz et al., 2014). ONIOM, a powerful hybrid method
implemented in the Gaussian 09 package (Vreven and Morokuma,
2006), was used to estimate the binding energy of the Ligand-ER
model complexes (ES-ER and G-ER).
In this work, we used a three-layer ONIOM (B3LYP/6-
31 þ G(d):PM6:AMBER) scheme and a two-layer ONIOM(P-
M6:AMBER) scheme to optimize the Ligand-ER and ER models,
respectively. This includes estradiol or glyphosate (B3LYP/6-
31 þ G(d)), the active site (PM6), and the environment (AMBER).
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Likewise, for the ES-W and G-W models, we used a three-layer
ONIOM(B3LYP/6-31 þ G(d):PM6:AMBER). This included estradiol
or glyphosate (B3LYP/6-31 þ G(d)), a water shell of 29 residues
surrounding the ligand (PM6) and the remaining water (AMBER).
Finally, for the Wmodel we used a two-layer ONIOM(PM6:AMBER)
comprising a water shell of 29 residues (PM6) and the remaining
water (AMBER). The results of ﬁnal energy of ONIOM calculations
(hartree) are reported in Table 1. The main property to be consid-
ered is the binding energy of the G-ER complex, which could be
deﬁned with the following equation: G-W þ ER/ G-ER þ W, in
other words DEG-ER ¼ {EG-ER þ EW} - {EG-W þ EER}. Finally, the
binding energy of the G-ER complex (DEG-ER) is compared to the
binding energy of the ES-ER complex (DEES-ER) to conclude on the
binding of glyphosate to the ER.
3. Results
In this investigation we compared the estrogenic capability
in vitro of glyphosate, two forms of the polyethoxylated tallow-
amine co-formulant (technical grade and agricultural spray adju-
vant), and 4 commercial GBH formulations containing different
ratios of co-formulants to that of estradiol and BPA (Fig. 1). An E-
Screen assay was performed to determine if glyphosate was able to
mimic estrogen-dependent cell proliferation (Fig. 1A). The positive
control 17b-estradiol was very potent in inducing the proliferation
of hormone-dependent MCF-7 human breast cancer cells, with the
concentration required to elicit a 50% response (AC50) being
0.0013 mg/L. BPA was also able to promote cell growth
(AC50 ¼ 46 mg/L) at concentrations 10,000 to 100,000 higher than
17b-estradiol (Fig. 1A). Glyphosate promoted growth of the same
cells starting at a concentration between 1000 and 10,000 mg/L and
peaking at 100,000 mg/L (Fig. 1A, upper panel). Similar but less
pronounced results were observed with the T47D cell line with
cells retaining a response to glyphosate but not Roundup Probio
(Fig. 1A, middle panel). This lower response of T47D cells may be
accounted for the fact that they possess lower levels of ERa (Parl,
2000). Additionally, no proliferative effects were observed in the
ER-negative, hormone-independent MDA-MB-231 cell line, sug-
gesting that proliferative effects were mediated via the ER (Fig. 1A,
lower panel). The commercial GBH formulation Roundup Probio,
tested at an equivalent glyphosate concentration, induced a non-
signiﬁcant trend of proliferation in the MCF-7 cell line (Fig. 1A,
top panel). Roundup Probio did not show ER activity at a glyphosate
equivalent concentration, which induced a cell proliferative effect
when glyphosate is tested alone. This may be explained by poten-
tially higher toxicity of commercial GBH formulation (Fig. 1A),
which could have resulted in cell death at the higher
concentrations tested.
Glyphosate alone, but not Roundup Probio, was able to stimulate
ERE-mediated transcription of the luciferase reporter gene starting
at a concentration of 1000 mg/L (Fig. 1B). The test of two other
commercial formulations, Roundup Original DI and Roundup Grand
Travaux Plus, also gave negative results (data not shown). We also
assayed a lower grade glyphosate, from AccuStandard, in an effort
to conﬁrm previously published results suggesting an estrogenic
potential of this compound at a range of concentrations around
109 M (Thongprakaisang et al., 2013). The results we obtained
were similar to those for PESTANAL® Analytical Standard glypho-
sate (Fig. 1B); that is, a luciferase reporter gene activation was eli-
cited from 1000 mg/L (data not shown). In order to evaluate
whether the cell proliferation and luciferase reporter gene stimu-
latory effects observed with glyphosate were mediated by through
the ER, we next performed experiments with the addition of the
potent antagonist ICI 182,780 (Fig.1C). This antagonist was effective
at suppressing ER activation induced by 0.001 and 0.01 mg/L but not
at 0.1 mg/L of 17b-estradiol. The addition of ICI 182,780 effectively
blocked the stimulatory effects of 2000e20,000 mg/L glyphosate,
conﬁrming agonist-like effects of this compound (Fig. 1C).
The investigation of the toxicological proﬁle of the GBH sur-
factant POEA has been deﬁned as a priority by EFSA (EFSA, 2015).
We tested the estrogenic potential of technical grade POEA, of an
agricultural surfactant mixture containing 60e80% POEA, and of a
GBH commercial formulation (Glyphogan) containing 13e18%
POEA. Our results clearly indicate that POEA is not estrogenic.
POEA, alone or with glyphosate in a commercial formulation, did
not induce the proliferation of MCF-7 cells (Fig. 2A) and failed to
induce ERE-mediated luciferase reporter gene expression in T47D-
KBluc cells (Fig. 2B). We obtained similar negative results with the
agricultural POEA surfactant mixture with all cell lines and assays
(data not shown).
MCF-7 cells treated for 48 h with glyphosate, the GBH formu-
lation Roundup Probio, the adjuvant POEA, or bisphenol A, and the
natural hormone 17b-estradiol were subjected to a full tran-
scriptome proﬁling. Table 2 displays the 10 genes having the
highest fold-change in expression, either down- or up-regulated.
These data were then compared to a gene expression biomarker
consisting of 46 genes with consistent expression changes after
exposure to 7 agonists of ER (Ryan et al., 2016). The biomarker has a
balanced accuracy for prediction of ERa activation of 94%. Genes
having their levels altered after treatment with glyphosate were
compared to the ER gene expression biomarker using the Running
Fisher algorithm as previously described (Ryan et al., 2016). The
cut-off for statistical signiﬁcance was p-value  0.0001 after a
Benjamini-Hochberg correction of a ¼ 0.001. Transcriptome proﬁle
Table 1
Molecular dynamics simulations and ONIOM calculations of glyphosate and estradiol-estrogen receptor models. Since the charge of glyphosate (G) is 2, the ligand-
receptor system was kept neutral by changing the charge of histidine residues of the environment (medium that surrounds the active site; that is, the remaining protein
plus water) or of the active site itself. The ONIOM theory level of B3LYP:PM6:AMBER and PM6:AMBER were used for the Ligand-ER and ER models respectively. The ﬁnal
ONIOM energy (Hartrees) is presented. The modiﬁcation of the charge of the active site induced a big structural distortion in ER, thus the model G-ER:11 was not reliable.
Models Histidine Charge Total charge ONIOM energy DE (kcal mol1)
Envir. Act. Site Envir. Act. Site
ES-ER HIE 356, HID 398 HIE 524 0 0 0 948.69 25.79
G-ER:11 HIP 356, HID 398 HIP 524 1 1 0 984.14 16.15
G-ER:20 HIP 356, HIP 398 HIE 524 2 0 0 988.87 4.10
ER:00 HIE 356, HID 398 HIE 524 0 0 0 97.79 Nr
ER:11 HIP 356, HID 398 HIP 524 1 1 2 93.57 Nr
ER:20 HIP 356, HIP 398 HIE 524 2 0 2 98.27 Nr
ES-W nr nr nr nr 0 876.61 Nr
G-W nr nr nr nr 2 916.35 Nr
W nr nr nr nr 0 25.75 Nr
ES, estradiol; G, glyphosate; ER, Estrogen Receptor;W,Water; HID, histidine residue protonated in the d (“delta”) position; HIE, histidine residue protonated in the ε (“epsilon”)
position; HIP, histidine residue protonated at both positions; Nr, not relevant.
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alterations resulting from exposure to BPA and estradiol (Fig. 3A)
were highly statistically signiﬁcant due to the similar expression of
biomarker genes in terms of fold-changes and direction to that of
the biomarker. Glyphosate treatment at the highest concentration
(10,000 mg/L; Fig. 3A) produced changes in the expression of only 3
genes present in the ER biomarker (p-value ¼ 0.0037, Fig. 3C),
which did not achieve the threshold for activation. The analysis of
gene ontology conﬁrms that genes having their expression altered
by treatment of MCF-7 cells with 10,000 mg/L glyphosate were
involved in cell cycle regulation, as well as in stimulation by steroid
hormones (Fig. 3B). The transcriptome of glyphosate-treated cells
was also reﬂective of cell death through apoptosis. The GO terms
“regulation of apoptotic process” and “cell death”were signiﬁcantly
enriched (FDR adjusted p-values of 2.3e-5 and 2.0e-5, respectively)
in MCF-7 cells treated with 10,000 mg/L glyphosate, but not at the
two lower concentrations tested.
We also measured the effects of the commercial GBH formula-
tion Roundup ProBio, and of the adjuvant POEA, on the tran-
scriptome proﬁles of hormone-dependent MCF-7 human breast
cancer cells. POEA was tested at two sub-cytotoxic concentrations
(10 mg/L, 100 mg/L). Roundup ProBio was assessed at the glyphosate
equivalent concentrations of 1 mg/L (environmental level), 100 mg/L
and 1000 mg/L (showing a cell proliferative trend). The statistical
analysis of differential expression showed that genes having their
function altered by Roundup or POEA had low fold changes
(Table 2). No geneswhose expressionwas increased or repressed by
POEA treatment had fold changes higher than 2. Although we
consider that low fold changes in expression of a sufﬁcient number
of genes can have a toxicological relevance (Mesnage et al., 2015a),
the study of transcriptome proﬁles shows that POEA alone is un-
likely to have estrogenic effects. This was conﬁrmed in that none of
the treatments exhibited statistically signiﬁcant correlations to the
ER biomarker (Fig. 3A,C).
In order to conﬁrm endocrine disturbances provoked by
glyphosate, RNA extracted from MCF-7 cells treated with glypho-
sate (10,000 mg/L), estradiol (0.27 mg/L) or bisphenol A (80 mg/L) for
48 h were subjected to a full RNA-Seq analysis using the Illumina
sequencing platform. The expression of genes found commonly
altered in both the microarray and the RNA-seq analysis were well
correlated (Fig. 4A) for 17b-estradiol (Pearson r ¼ 0.81), BPA
(r ¼ 0.86) and glyphosate (r ¼ 0.71). Overall, the RNA-seq method
was more sensitive and identiﬁed 2e3 times more genes whose
expression was signiﬁcantly altered compared to the microarray
approach (Fig. 4B). A total of 5102, 2939 and 1083 genes had their
expression signiﬁcantly disturbed by estradiol, BPA and glyphosate,
respectively. Although their gene expression proﬁles were
different, MCF-7 cells treated by these 3 chemicals presented al-
terations reﬂecting a response to steroid hormones and a modu-
lation of cell proliferation, although the signiﬁcance of the
overlapping genes and those in these pathways was lower for
glyphosate than the other compounds (Fig. 4C). We next applied
the ER gene expression biomarker (Ryan et al., 2016) to see if we
could detect ERa agonist effects after transcriptome proﬁling using
RNA-Seq (Fig. 4D and E) platforms. The results were similar to those
Fig. 1. Glyphosate at high concentrations can substitute for estradiol in promoting cell growth through estrogen receptors in human breast cancer cells. (A) Proliferative
effect of glyphosate and Roundup Probio in an E-Screen bioassay. Hormone-dependent (MCF-7, T47D) and hormone independent (MDA-MB-231) human breast cancer cells were
cultured under hormone-free conditions (n ¼ 6). Proliferative effects by MTT assay following 6 days exposure to either glyphosate or Roundup Probio with estradiol and bisphenol A
treatments acting as positive controls at the indicated concentrations. Proliferation is expressed as a percentage increase in cell number compared to culture in the absence of the
natural hormone or test substance. Upper bound and lower bound of the biological variability (SEM) of the non-treated cells (negative control) are represented by dotted lines. M,
proliferative effect of medium containing non-steroid hormone stripped FBS. (B) Estrogen receptor activation in T47D-Kluc cells harbouring a ERE-luciferase reporter gene. Cells
were treated for 24 h with glyphosate alone, a Roundup formulation (Roundup Probio), BPA or estradiol and activation of expression measured by a bioluminescence assay (n ¼ 4).
(C) Luciferase assays of T47D-Kluc cell cultures treated with glyphosate or estrodiol in the absence (black squares, circles) or presence (white squares, circles) of the estrogen
antagonist ICI 182,780 (n ¼ 4). Note decrease in luciferase reporter gene expression indicating action of test substances via the ER.
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obtained using the microarray data; glyphosate failed to pass the
threshold of signiﬁcance for ERa activation. Although the RNA-seq
platform was able to identify more statistically signiﬁcant genes
than microarrays, the genes altered differed between the two
methods. Among those that are part of the ERa activation
biomarker, the genes that were altered by glyphosate in the
microarray analysis (CD44, PGR, and MYB) were different from
those identiﬁed by RNA-seq (CXCl12, ABHD2, and EFNA1).
The ability of glyphosate to bind to ERa was evaluated by mo-
lecular dynamics simulations and ONIOM calculations. Since the
charge of glyphosate (G) is2, the ligand-receptor systemwas kept
neutral by changing the charge of histidine residues of the envi-
ronment (medium that surrounds the active site; that is, the
remaining protein plus water) or of the active site itself (Table 1). An
analysis of root mean square deviations (RMSD) of the lowest en-
ergy structures originating from the ER molecular dynamics sim-
ulations was performed on 230 residues (6 / 235). Our results
indicate that ER:11 (RMSD ¼ 2.014) presents a larger structural
deviation than ER:20 (RMSD ¼ 1.474). The charge on histidine
524 at the active site induces some structural distortion in ER and
the ER:11 model was thus discarded. In relation to the number of
active site water molecules (Table 1), the behaviour of ER:20/ G-
ER:20 is similar to the reference ER:00/ ES-ER. A number of water
molecules are replaced by the ligand, and by virtue of the above, the
addition of the charges in the environment does not produce too
large a distortion in receptor protein structure.
The three crucially important residues for estradiol binding to
ER via the creation of a hydrogen bond network are HIS 524, GLU
353 and ARG 394 (Fig. 5C). In addition, there are 3 water molecules
within 4 Å of the estradiol molecule within the active site. The
binding of the hydroxyl group at the C17 position to HIS 524
maintains ER in the active conformation. The interaction with the
opposite side of the estradiol molecule (with the hydroxyl group at
the C3 position), is stabilized by creating a hydrogen bound
network with ARG 394, GLU 353 and a water molecule. Aside from
these hydrogen bonds, the active site is mostly hydrophobic and is
thus appropriate for binding of estradiol. Results from the molec-
ular dynamics simulations of glyphosate-ER interactions reveal that
glyphosate enters the active site with a large number of water
molecules (Fig. 5B). The glyphosate phosphate group interacts with
ARG 394 by creating hydrogen bonds. (Note: arginine residue is
positively charged.) A total of 21 water molecules enter the active
site within 4 Å of the glyphosate; these molecules are mostly
located at one side of the glyphosate molecule. The positively
charged LYS 529 residue (which does not belong to the active site),
stabilizes the opposite end of the glyphosate molecule (at the
carboxyl group) by creating a water hydrogen bond network.
Furthermore, on the other side of the ER binding site, LEU 387 and
LEU 391maintain hydrophobic contacts with themethylene groups
of glyphosate. We notice that glyphosate is unlikely to interact with
HIS 524, a residue having a pivotal role in maintaining protein
structure in the biologically active agonist conformation. The
ONIOM binding energy of G-ER:20 (4.10 kcal mol1) is approxi-
mately 6 times greater than ES-ER (25.79 kcal mol1). These re-
sults strongly imply that the binding of glyphosate at the active site
of the receptor is weak and unstable, suggesting that glyphosate is
Fig. 2. Comparison of cell growth and estrogen receptor activation in human breast cancer cells treated with glyphosate, a GBH (Glyphogan), or POEA: a glyphosate-based
herbicide adjuvant (polyethoxylated tallow amine; POEA) is not estrogenic in human mammary cells. (A) Proliferative effect of glyphosate alone, a glyphosate-based herbicide
containing the adjuvant POEA (Glyphogan), or POEA alone in the E-Screen bioassay. Hormone-dependent MCF-7 human breast cancer cells were cultured under hormone-free
conditions (n ¼ 4) and proliferative effects measured by MTT assay following 6 days exposure to either the natural hormone (estradiol) or test substance (Glyphogan, POEA).
(B) Glyphosate but not Glyphogan Roundup formulation or POEA stimulate ERE-luciferase reporter gene expression in T47D-Kluc cells. T47D-Kluc cells were treated for 24 h with
the test substances and then subjected to a bioluminescence luciferase reporter gene assay (n ¼ 4). þ/, indicates the presence or absence of the indicated chemical.
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unlikely to bind to ERa.
Based on the results of the molecular dynamics simulations and
the results of ERa biomarker, we hypothesized that the increase in
ERE-luciferase reporter gene expression caused by glyphosate
(Fig. 1) is due to a ligand-independent mechanism. A possible route
for this ligand-independant activation is via cellular pathways
(such as the cAMP-dependent protein kinase (PKA) pathway) that
modulate the balance between cell proliferation and apoptosis
(Berger et al., 2013). In order to show that the ERE-luc reporter is
responsive to ligand-independent activation, we treated the T47D-
Kluc cells with 500 mM of 3-isobutyl-1-methylxanthine (IBMX), an
activator of the PKA pathway which raises cAMP levels, and
monitored activation of the ERE-luciferase reporter gene. Our result
(Fig. 6) shows that 500 mM IBMX was able to stimulate ERE-
mediated transcription of the luciferase reporter gene. Further
studies would be needed to determine if glyphosate modulates the
PKA pathway.
4. Discussion
A previous study reported observation that glyphosate exhibi-
ted estrogenic activity in promoting MCF-7 cell proliferation and
inducing ERE-mediated-luciferase reporter gene expression in the
T47D-KBluc cells at concentrations comparable to those of estradiol
(Thongprakaisang et al., 2013). We were not able to replicate these
results. However, it should be noted that our experimental condi-
tions differed to a small degree from those of Thongprakaisang and
colleagues and were not directly comparable with our estrogen
withdrawal period during cell culture was shorter (1 day vs 5 days).
It is possible that the estrogen withdrawal protocol used in the
present study may not be long enough for clearance of residual
estrogen and may thus affect the dose of glyphosate needed to
activate the ERE luciferase reporter gene. However, we believe that
this difference in the duration of the estrogen withdrawal period
between our study and that of Thongprakaisang and colleagues is
not a signiﬁcant contributing factor to the observed differences in
experimental outcome. First, we optimized our protocol to reach
the required sensitivity to detect the activity of weak agonists such
as bisphenol A (Mesnage et al., 2017a). Second, the ﬁnding of
Thongprakaisang and colleagues that a dose of 10e-12 M of
glyphosate had a greater estrogenic effect than estradiol raises
major concerns and suggests the possible presence of contami-
nants. Third, it is surprising that Thongprakaisang and colleagues
were not able to ﬁnd a no observable effect level for glyphosate in
Table 2
List of the 10 most up- or down-regulated genes after the treatment by glyphosate, Roundup, POEA, bisphenol A, or 17b-estradiol. MCF-7 cells treated by glyphosate
(1 mg/L,100 mg/L,10,000 mg/L), Roundup (1 mg/L of glyphosate,100 mg/L of glyphosate,1000 mg/L of glyphosate), by the adjuvant POEA, by bisphenol A (80 mg/L) or by the positive
control estradiol were subjected to a full transcriptome microarray analysis.
17b-estradiol (0.0027 mg/L) 17b-estradiol (0.027 mg/L) 17b-estradiol (0.27 mg/L) Bisphenol A (80 mg/L) POEA (100 mg/L) POEA (10 mg/L)
ALDH1A3 0.4 ALDH1A3 0.2 ALDH1A3 0.2 SEMA5A 0.3 NRF1 0.6 RNU7-163P 0.6
SEMA5A 0.4 PRICKLE2-AS3 0.2 PSCA 0.2 ALDH1A3 0.3 RNU6-1281P 0.6 SNORA54 0.6
PPARG 0.5 SEMA5A 0.3 TFPI 0.2 PSCA 0.3 RP3-486I3.5 0.6 IREB2 0.6
PSCA 0.5 PSCA 0.3 PRICKLE2-AS3 0.2 PRICKLE2-AS3 0.3 SNORA54 0.7 LINC00403 0.6
IGFBPL1 0.5 EPAS1 0.3 EPAS1 0.3 GABBR2 0.3 RNA5SP144 0.7 RP11-10N23.2 0.6
EPAS1 0.5 TFPI 0.3 LIPH 0.3 EPAS1 0.3 RP3-425P12.5 0.7 ANKRD10-IT1 0.6
PSCA 0.5 LIPH 0.3 SEMA5A 0.3 LIPH 0.4 RNU7-75P 0.7 COX17 0.6
S1PR3 0.5 SAT1 0.3 DAB2 0.3 PPARG 0.4 RNU6-1024P 0.7 RP11-473O4.4 0.6
MIR3911 0.5 PSCA 0.3 SAT1 0.3 PSCA 0.4 HIST2H2AB 0.7 RNU6-385P 0.6
RP11-398B16.2 0.5 RND1 0.3 PSCA 0.3 UPK2 0.4 AC099344.2 0.7 ACTL6A 0.6
RNU6-807P 2.3 EGR3 5.2 MYBL1 5.5 MYB-AS1 2.8 RP5-865N13.1 1.4 LOC339978 1.4
MYB-AS1 2.5 MYBL1 5.5 EGR3 5.6 MGP 2.9 LOC100506142 1.4 LOC100134937 1.4
STC1 2.5 MYB 6.0 AC106875.1 6.4 AC005534.8 3.1 FKSG29 1.4 FLJ45079 1.4
AC005534.8 2.6 AC106875.1 6.3 GREB1 6.5 AC106875.1 3.3 RNA5SP39 1.4 MIR99A 1.4
MYB 3.0 GREB1 6.6 MYBL1 6.5 GREB1 3.3 TBX3 1.4 RP11-61L14.6 1.5
AC106875.1 3.2 GREB1 7.1 GREB1 7.1 MYB 3.7 LOC101927783 1.5 DHRS3 1.5
GREB1 3.2 MGP 7.2 PGR 7.1 GREB1 3.8 LINC00396 1.5 RP11-148B18.4 1.5
PGR 3.4 PGR 7.8 MGP 9.0 PGR 4.2 FLJ45513 1.5 MIR103B2 1.6
GREB1 3.7 PGR 10.0 PGR 9.2 MGP 4.2 MIR99A 1.5 MIR103A2 1.7
PGR 4.6 MGP 12.4 MGP 15.0 PGR 6.2 RNU6-601P 1.6 MIR425 1.8
Glyphosate (1 mg/L) Glyphosate (100 mg/L) Glyphosate (10,000 mg/L) Roundup (1000 mg/L of G) Roundup (100 mg/L of G) Roundup (1 mg/L of G)
RNU6-385P 0.5 RP3-486I3.5 0.4 SEMA5A 0.5 SNORA54 0.5 MIR548A2 0.5 LRCH3 0.6
TNXB 0.6 RNU7-141P 0.5 DXO 0.5 RNU4ATAC 0.5 NFE2L3 0.5 MIR4328 0.6
RNA5SP303 0.6 MYB 0.6 ALDH1A3 0.6 TNXB 0.6 RNU6-177P 0.5 LOC101928000 0.6
RNU6-667P 0.6 RNU7-172P 0.6 PRICKLE2-AS3 0.6 RNU6-611P 0.7 PGR 0.5 RNU5B-4P 0.7
RP11-276G3.1 0.7 RNU7-113P 0.6 RNU7-134P 0.6 TICAM2 0.7 SNORD58A 0.6 ZNF404 0.7
RNU6-611P 0.7 RNA5SP303 0.6 XXbac-BPG254F23.7 0.6 AC005304.1 0.7 RNU6-998P 0.6 RNU6-322P 0.7
TGFB1 0.7 MIR3662 0.6 RP11-417B4.2 0.6 RNU6-893P 0.7 LINC00403 0.6 ADAM20P1 0.7
CHIC1 0.7 RNU6-1024P 0.6 AC073046.25 0.6 ZNF202 0.7 TMEM123 0.6 RP11-77M5.1 0.7
CCIN 0.7 SNORD20 0.6 AAK1 0.6 VPS35 0.7 LOC101928000 0.6 RAD54L2 0.7
RP11-473E2.2 0.7 RNU6-998P 0.7 LIPH 0.6 MIR4514 0.7 MIR3140 0.6 RP11-276G3.1 0.7
CRTAP 1.5 PDE11A 1.5 AC005534.8 1.6 CRTAP 1.4 AL592528.1 1.5 AP001469.5 1.4
PTPRS 1.5 MIR3074 1.6 SNORA70B 1.6 MAST4-AS1 1.4 RNU6ATAC18P 1.5 PLEKHA4 1.4
SNORA5A 1.5 AC010894.3 1.6 MYB-AS1 1.7 SLC25A30-AS1 1.4 PAIP2B 1.5 SNORA70B 1.5
RP11-575A19.2 1.5 RNU6-306P 1.7 STC1 1.8 RNU6-853P 1.4 RP11-319F12.2 1.5 PCAT1 1.5
RNU6-1258P 1.5 RNU4-38P 1.7 MIR99A 1.8 RNU4-40P 1.5 SART3 1.6 ATP11A-AS1 1.5
RN7SKP56 1.5 MIR99A 1.7 AC106875.1 2.0 SNORA5A 1.5 RNA5SP498 1.6 RP5-865N13.1 1.5
LOC729451 1.5 MIR532 1.8 GREB1 2.1 RP5-1022J11.2 1.5 RNA5SP498 1.6 MIR4733 1.5
MIR532 1.6 MIR501 1.8 MYB 2.2 RP11-218L14.4 1.5 RP11-300E4.2 1.6 LOC101927557 1.5
ALG9 1.6 RNU6-1004P 2.3 PGR 2.3 RNU4-38P 2.0 RNU6-388P 1.7 SNORD41 1.7
SNORD59B 1.6 RNU4-60P 3.1 GREB1 2.4 SNORD1A 2.2 MIR4256 2.3 RNU4-62P 1.9
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their ERE-luciferase assay. In contrast our results suggest that
glyphosate is a weak activator of ERa in hormone-dependent hu-
man breast cancer cells and that it may exert this effect via a ligand-
independent pathway. The glyphosate intake necessary to reach a
systemic concentration representative of the estrogenic effects
shown here would only be encountered in cases of extreme ex-
posures (incidental ingestion, mishandling) (Niemann et al., 2015;
Roberts et al., 2010). GBH exposures causing acute moderate to
severe clinical outcomes are generally associated with glyphosate
plasma concentrations ranging from 18.9 to 104.2 mg/L, while
death occur at glyphosate concentrations larger than 734 mg/L
(Roberts et al., 2010). However, problems potentially arising from
chronic, environmentally relevant low dose exposure to GBHs as
well as to glyphosate per se have not been thoroughly investigated
although there is evidence to suggest that this avenue of investi-
gation is worth pursuing (Guyton et al., 2015; Mesnage et al., 2015b,
2017b).
It has been reported elsewhere that glyphosate can induce
proliferation of MCF-7 cells (Lin and Garry, 2000) at a concentration
that corresponds to that showing estrogenic effects in our experi-
ments (Fig. 1). Interestingly, in this previous study, glyphosate
provoked similar proliferative effects in both the presence and
absence of charcoal dextran-treated culture medium, suggesting
that proliferative effects were not mediated by activation of ER (Lin
and Garry, 2000). An evaluation of the glyphosate binding energy
conﬁrmed that this compound is unlikely to activate ER (Fig. 5). It is
known that estrogenic effects can be caused by an activation of ER
in a ligand-independent manner. The modulation of the phos-
phorylation of some protein kinases, as well as modiﬁcation at the
level of second messengers, can activate ER due to interplay
between cellular signalling pathways. For example, the suppression
of PI3K signalling results in induction of ER-dependent transcrip-
tional activity (Bosch et al., 2015). Proliferative effects provoked by
exposure to toxic agents changing the apoptosis/proliferation bal-
ance could be accompanied by an activation of estrogenic pathways
(Berger et al., 2013). The activation of p53 during apoptosis is
accompanied by an increased expression of ERa in MCF-7 cells
(Angeloni et al., 2004). This is due to protein-protein interactions
between ERa and p53 and p53 binding to the ESR1 promoter
(Berger et al., 2013). This provides one explanation for the observed
activation of ERa by glyphosate (Fig. 1). Glyphosate has been shown
to cause apoptosis, as measured by caspase 3/7 activation, at
10e20 mg/L (Benachour and Seralini, 2009; Koller et al., 2012). In
addition, glyphosate can act as a protonophore, causing a distur-
bance in liver cell mitochondrial respiration from ~10,000 mg/L
(Olorunsogo, 1990). This encompasses the concentrations at which
we observed estrogenic effects of glyphosate (Fig. 1) and thus
provides a possible mechanism of action.
The presence of glyphosate-associated cytotoxic effects could
also explain discrepancies between the results we obtained with
the ERa biomarker (Fig. 3) and those from the cellular assays
(Fig. 1). As shown (Fig. 1), the efﬁcacy of ERa activation by glyph-
osate through a receptor-independent mechanism is lower than for
BPA. If the resulting alterations in gene expression patterns by
glyphosate are weak, they may be below the threshold at which
correlations with the ERa biomarker can be made. However, this
lack of correlation between glyphosate cellular effects and the ERa
biomarker may also be due to the thresholds used to identify sta-
tistically signiﬁcant changes. Indeed, 42 out of the 46 genes that
constitute the ERa biomarker had their expression altered (up- or
Fig. 3. Determination of estrogenic effects of glyphosate through a gene expression biomarker of ESR1 activity. (A)MCF-7 cells following 24 h adaptation to steroid hormone-
free conditions were treated with the indicated concentrations of glyphosate, the commercial formulation Roundup Probio, POEA adjuvant or the natural hormone 17b-estradiol for
48 h. Transcriptome proﬁles of cell cultures following treatment was by microarray analysis. Lists of genes whose expression was statistically signiﬁcantly altered was then
scrutinized against an ER gene expression biomarker consisting of 46 genes (listed on right hand side). Results shown as a heat map showing the expression of genes in the ER
biomarker following exposure to the indicated compound. The fold-change values for ER biomarker genes are the average across 7 agonist treatments. (B) Gene ontology analysis
reﬂects hormone induced cell proliferative effects. The p-values are determined by a hyper-geometric calculation and corrected for multiple comparisons (FDR). (C) Bar plots
showing the signiﬁcance of the correlation by their elog10 (p-value)s. Classiﬁcation of activation or suppression required p < 0.0001.
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down-regulated) in conformity with the biomarker but failed to
pass the threshold for statistical signiﬁcance (data not shown).
Our ﬁnding that PKA activation by IBMX can induce ERa-
mediated reporter gene expression (Fig. 6) suggests that the ERE-
luc reporter is responsive to ligand-independent activation. The
stimulation of PKA signalling pathway, increasing cAMP levels, is
known to activate the transcriptional activity of ESR1, even in the
absence of ligand, by associating with cyclin D1 (Driggers and
Fig. 4. Comparison of RNA-seq and microarray platforms in evaluating potential endocrine disrupting effects of glyphosate. RNA extracted fromMCF-7 cells were subjected to
a full transcriptome proﬁling using the Illumina RNA sequencing (RNA-Seq) or Affymetrix microarray technology platforms. (A) Pearson correlation coefﬁcients between the RNA-
Seq and microarray data. The fold changes of genes having an altered expression by the two methods are presented. (B) Venn diagrams showing the number of genes uniquely or
commonly disturbed in the RNA-seq or the microarray platforms. (C) Gene ontology analysis of terms associated to MCF-7 hormone-induced proliferation in the transcriptome
proﬁles obtained by RNA-seq or microarray experiment analyzed using the Thomson Reuters MetaCore Analytical Suite recognizing network objects (proteins, protein complexes or
groups, peptides, RNA species, compounds among others). The p-values are determined by hypergeometric calculation and adjusted using the method of Benjamini & Hochberg.
Ratios show the total number of network objects belonging to each term in comparison to those disturbed by the treatments. (D) Heat map of statistically signiﬁcant genes
examined against an ER gene expression biomarker (gene list on the right hand side, p-values of <0.05 with fold change > 1.2). (E) Bar plots showing the signiﬁcance of the
correlation between each bioset and the ER biomarker (elog10 (p-value)s. Classiﬁcation of activation or suppression required p < 0.0001.
Fig. 5. Molecular dynamics simulation of glyphosate and estradiol binding to human estrogen receptor alpha (ERa). (A). ER Model showing the position of the active (ligand
binding) site of ERa. (B). Glyphosate (ball and stick depiction) binding simulation at the ER active site is weak and less stable (G-ER:20 model, binding energy of 4.10 kcal mol1).
Distances between interacting heteroatoms are listed in Ångstrøms. The environment water molecules are not shown. (C). Estradiol (ball and stick depiction) binds strongly to ER
(ES-ER model, binding energy of 25.79 kcal mol1); this binding speciﬁcity and stability is conferred by a network of direct and water (stick) molecule-mediated interactions. Note:
the water molecule constituting a bridge between ES and ARG 394.
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Segars, 2002). It is thus plausible that glyphosate is activating ERa
through a ligand-independent mechanism albeit at high concen-
trations. However, further studies would be needed to determine if
glyphosate modulates the PKA pathway or another signalling
pathway. Compounds that function through ligand-independent
ERa activation may fail to be detected by the ERa biomarker,
which was established to detect activity of agonist and antagonist
functioning directly through ERa (Ryan et al., 2016). The observa-
tion that ligand-independent (growth factors and cAMP) and
ligand-dependent (estradiol) activation of ER have distinct ERa-
dependent transcriptional responses in MCF-7 cells (Dudek and
Picard, 2008) supports such a mechanism. Additionally, liganded
and unliganded activation of ER has been shown to give a different
pattern of phosphorylation of this receptor (Maggi, 2011). There-
fore, future studies determining the phosphorylation of ERa could
provide new insights into the mechanism by which glyphosate
activates various signalling pathways. This could also be studied by
the investigation of the effects of signalling pathway inhibitors on
glyphosate-induced ERE activation. A previous study in ERE-Luc
reporter gene transfected MCF-7 cells shows that 1 mM of for-
skolin, an activator of the PKA pathway, could induce ERE activation
but with a lower potency than 10 nM of E2. Furthermore, H89, a
PKA inhibitor could not reverse E2-induced ERE activation (Yum
et al., 2009).
The comparison of estradiol and glyphosate binding energies
shows that glyphosate is unlikely to activate ERa in a similar
manner to the natural hormone. Our results are consistent with
those of previously published studies, which reported that glyph-
osate ER activity is negative in the Collaborative Estrogen Receptor
Activity Prediction Project (CERAPP) (Mansouri et al., 2016). This is
not altogether surprising since glyphosate and estradiol are struc-
turally very distinct, with glyphosate not displaying the features of
ER agonists. The structural features of glyphosate making it an
unlikely ER agonist can clearly be seenwhen comparing it to known
estrogen mimics such as BPA. The binding free energy of estradiol
and BPA to ER has been shown to be 34.88 kcal/mol
and 23.77 kcal/mol, respectively (Li et al., 2015). BPA binding to
ERa is comparable to that of estradiol, with two phenol moieties
pointing to the two ends of the ER hydrophobic pocket, one ring to
residue Glu 353 and the other to His 524 (Li et al., 2015). As a
consequence, BPA traps the twelfth helix (H12) of the binding
pocket in an active conformation, allowing the binding of a coac-
tivator in order to transduce downstream gene transcription sig-
nalling (Li et al., 2015). As glyphosate lacks features such as the two
phenol moieties possessed by BPA this could evidently account for
its ability to stably interact with the ER ligand binding site even in
the presence of potential associated water molecules. However, our
model did not take into account the capacity of glyphosate to bind
cations and it is possible that the chelating properties of glyphosate
may inﬂuence its biological activity at the level of binding to ERa.
Although the health risks of the stated active principle of a given
pesticide are evaluated by regulatory agencies, in reality exposures
to both animal and human populations also include the adjuvants
that are invariably present in commercial products. In order to
determine any estrogenic potential of adjuvant co-formulants, we
tested a number of GBH formulations (Roundup ProBio, Glyphogan,
Roundup Grand Travaux Plus, and Roundup Original DI). Our results
(Fig. 1) did not show any estrogenic effects. However, we did
observe cytotoxicity at glyphosate-equivalent concentrations lower
than those required to elicit a proliferative response to glyphosate
alone. We have demonstrated that commercial formulations can be
up to 1000 times more toxic than glyphosate in human cell lines
due to surfactant-mediated cell membrane disruption, with POEA
being ~10,000 times more toxic than glyphosate alone (Mesnage
et al., 2013). However, the composition of co-formulants of
different formulations is variable. The characterisation of the po-
tential for endocrine-mediated mode of action of POEA has been
deﬁned by EFSA as a data gap precluding a proper risk assessment
(EFSA, 2015). POEA is considered as a major contributor to in-
cidences of poisoning in humans. In particular, the recent review of
the toxicological proﬁle of POEA by EFSA highlights concerns about
its genotoxic potential regarding DNA damage at concentrations
that do not cause cytotoxicity, as well as potentially severe repro-
ductive and developmental toxicities (EFSA, 2015). We report here
for the ﬁrst time the lack of endocrine-disrupting effects of POEA at
the level of ER. Other studies have reported that POEA can inhibit
aromatase (a key enzyme in the balance of sex hormone produc-
tion) in human placental tissue culture cells (Defarge et al., 2016).
This effect is explained by the known disturbance of the endo-
plasmic reticulum, as surfactants such as POEA are known to
disrupt membrane structure (Cserhati, 1995).
In conclusion, our investigation reveals that glyphosate activates
ERa in breast cancer cells but only at relatively high concentrations,
and that this activation is through a ligand-independent pathway.
This result is in contrast to a previous study, which reported that
glyphosate could activate ER with a potency similar to estradiol.
Our results suggest that humans exposed to glyphosate would not
exhibit ER activation at typical exposure levels. However, the clin-
ical relevance of human exposure to glyphosate, either alone or
mixed with natural hormones, hormonal therapies, or other envi-
ronmental pollutants, warrants further investigation.
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